Viatris Inc. VTRS
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NASDAQ · United States · viatris.com
Viatris Inc. is a global healthcare company that provides prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients. The company operates through segments including Developed Markets, Greater China, JANZ, and Emerging Markets, serving therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. Headquartered in Canonsburg, Pennsylvania, Viatris serves patients in more than 165 countries and territories.
Key ratios
FreeCashFlowOnSale TTM 0.14
FreeCashFlowOnSale 2025 0.14
FreeCashFlowOnSale 2024 0.13
FreeCashFlowOnSale 2023 0.16
NetIncomeMargin TTM -0.25
NetIncomeMargin 2025 -0.25
NetIncomeMargin 2024 -0.04
NetIncomeMargin 2023 0
ReturnOnAssets TTM 0.02
ReturnOnAssets 2025 0.02
ReturnOnAssets 2024 0.02
ReturnOnAssets 2023 0.03
ReturnOnEquity TTM -0.21
ReturnOnEquity 2025 -0.21
ReturnOnEquity 2024 -0.03
ReturnOnEquity 2023 0
Recent news
Viatris Completes €650 Million 4.250% Senior Notes Due 2033 to Refinance 2026 Debt
2026-06-18 · TradingView